Infrared and Raman spectroscopy are effective techniques that allow collecting information about secondary structure of proteins, including antibodies. Trastuzumab, antibody used in our study was in a freeze-dried form, conjugated with different bifunctional chelators and linked with the stable isotopes of lutetium and yttrium. The characterization of the final immunoconjugates showed no significant changes in the structure demonstrated by the presence of the amide bands characteristic for a α-helices and β-sheets structures. These methods could be applied during the production of the antibody freeze-dried kit formulations for the labeling with the radioactive isotopes.
Introduction
The use of monoclonal antibodies (MAbs) is a well-known type of targeted anticancer therapy. A typical strategy for the treatment of cancer is focused on targeting and killing fast dividing cells. This approach requires to achieve high target specificity and, as a result, has led to designing and synthesizing a number of highly selective monoclonal antibodies. Selective targeted therapy allows imparting less toxicity to healthy cells, thus causing insignificant side effects [1, 2] . The high selectivity and specificity of monoclonal antibodies are usually exploited for the production of a variety of immunoconjugates where the antibody is linked either to cytotoxic drugs and toxins or to radioisotopes. Each of these conjugates carries its own therapeutic cargo and, therefore, exhibits an intrinsic toxicity [3] . Drug immunoconjugates have the potential advantage over the free drug substance of enhancing drug delivery to tumor cells with a concomitant reduction of drug resistance. Immunotoxins are very interesting tools for investigation because of their high specific biological activity [4] , whereas radiolabeled antibodies have the additional advantage that can be used also for molecular imaging [5] .
Only two radiolabeled antibodies have been commercially approved namely 131 I-tositumomab and 111 In/ 90 Yibritumomab tiuksetin. Both radiopharmaceuticals are anti-CD20 radiolabeled MAbs and are indicated for the treatment of B cell lymphoma [6] . Until now, a series of clinical and preclinical trials of breast cancer imaging and therapy with radioimmunoconjugates has been carried out [7] [8] [9] [10] [11] [12] [13] . Many efforts have been devoted to obtain stable trastuzumab conjugates with different radioisotopes, while preserving the native antibody's immunoreactivity. Two freeze-dried kit formulations were developed for labeling DTPA-and DOTAGA-trastuzumab derivatives with 111 In to afford 111 In-DTPA-trastuzumab and 111 In-DOTAGA-trastuzumab, which are important cancer imaging agents [DTPA = diethylene triamino-pentaacetic acid and DOTAGA = 2,2′,2″-(10-(4-((2-aminoethyl) 1 3 amino)-1-carboxy-4-oxobutyl)-1,4,7,10-tetraazacyclododecane-1,4,7 triyl) triacetic acid] [7] [8] [9] . Similarly, a stable 67 Ga-DOTA-trastuzumab conjugate (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was prepared and showed to be a powerful imaging agent for the diagnosis of breast cancer [10] . Palm et al. [11] Lu using DOTA as chelator. In vitro and in vivo investigations in mice grafted with breast tumor, revealed that 177 Lu-DOTA-trastuzumab is a new promising radio-immunoconjugate for the potential treatment of human breast cancer. Subsequent investigations evaluated the conjugation of the alpha emitter 227 Th to trastuzumab via the chelating moiety DOTA-p-benzyl. In rodent models of HER2 positive breast and ovarian cancers, this radio-immunoconjugate showed a remarkable therapeutic efficacy [13] .
It should be noted that the bifunctional chelators (BCFs) DOTA and the DTPA derivative 1B4M-DTPA[IB4M-DTPA = 2-(4-isothiocyanatobenzyl)-6-methyl-diethylenetriaminepentaacetic acid], are the most widely investigated for a successful labeling of antibodies with metallic radionuclides [14] . Schematic drawings of the chemical structures of these BFCs are illustrated in Fig. 1 .
Generally, radiolabeling is carried out by combining the BFC-derivatized antibody with the appropriate radionuclide precursor in aqueous solution. However, due to antibody's instability in the liquid state or need of the gold chain of keeping, freeze-drying is frequently the method of choice for long-term storage and stabilization of the protein structure. Obviously, such an approach always demands to develop a suitable process for the preparation of freeze-dried, solidstate formulations to store up the BFC-antibody [15] . Then, these freeze-dried antibody's samples can be conveniently mixed in solution with the radionuclide to accomplish the labeling reaction. It turns out that this procedure raises immediately the crucial question about how to evaluate the impact on the whole protein of the chemical derivatization of the antibody with the pendant BFC followed by the freezedrying process and final labeling with a radiometal. This information is essential to clearly understand the factors that may affect the antibody's molecular structure and, consequently, its immunoreactivity.
Aim of the present study is to explore the application of a spectroscopic approach to assess the degree of preservation of the normal antibody's molecular arrangement after BFC derivatization, freeze-drying and metal coordination. Actually, infrared (IR) and Raman spectroscopy (RS) are among the appropriate experimental techniques for the analysis of the antibody's secondary structure and detection of possible structural disorders originated by some physical and chemical perturbation [16, 17] . To mimic the effect of the labeling reaction with the radiometal, and non-radioactive labeling procedure have been developed using the stable, natural isotopes of lutetium (Lu) and yttrium (Y). This cold-labeling approach avoids the problem of presence of radioactive decay during the examination and it was easier to determine the possible physicochemical changes in the structure of immunoconjugates after metal binding.
IR and RS are powerful, non-destructive and easy-touse techniques providing valuable molecular structural information showing their sensitivity to the presence of specific amino acids distributions in peptides, proteins and enzymes. More precisely, these techniques can detect tiny spectroscopic changes originating inside the secondary antibody's structure as a result of conjugation, lyophilization and cold labeling processes [18] [19] [20] . For instance, in Raman scattering, the output signal is uniquely associated to a specific molecule. The scattered energy and frequency are lower than for the incoming photon, the lost energy being characteristic for each bond in the molecule and, hence, associated with a characteristic wavelength [21] . On the other side, IR absorbed radiation depend on Fig. 1 Chemical structure of the bifunctional chelators employed in this study the strength and polarity of the chemical bonds and on intra-and intermolecular interactions, thus providing key molecular information for systems composed by complex arrangements of amino acids such as small peptides, proteins, enzymes, peptide-protein complexes, membranebound proteins and intact membranes [18, 22] . It is interesting to note that IR vibrations of peptide groups depict up to nine characteristic bands designated as amide I-VII and A and B, where amide I and II comprise bands having the strongest intensity in the protein IR spectrum [19] . Collateral techniques that may complement and corroborate the molecular information collected with IR and RS are mass spectroscopy (MS) [23] , circular dichroism (CD) [24] , nuclear magnetic resonance spectroscopy (NMR) [25] and X-ray crystallography [26] .
Trastuzumab is a potent anti-HER2/neu (HER = human epidermal growth factor receptor) humanized monoclonal antibody, active in patients with advanced metastatic breast cancer [2] . Therefore, this antibody has been selected as a model protein to evaluate the efficacy of the outlined approach. In particular, the secondary structure of trastuzumab was screened by IR and RS vibrational spectroscopy after conjugation of trastuzumab to the three (Fig. 1) . Similarly, the same measurements have been carried out after both lyophilization of the immunoconjugate and subsequent cold-labeling with stable Y and Lu metals.
Experimental

Conjugation of trastuzumab with BFCA
The antibody trastuzumab (Tr) was obtained as the main component of the commercial product Herceptin ® (Hoffmann-La Roche, Basel, Switzerland) and was purified using an Amicon ® Ultra-4 centrifugal filter (30 kDa) (Sigma Aldrich, Missouri, USA) and then conjugated to the appropriate BFCs in 1:20 molar ratio (Mab:BFC). Briefly, a calculated volume of a solution (10 mg/mL) of the appropriate BFCs in 0.1 M PBS (pH 8) was added to the antibody and the mixture was incubated for 18 h at 4 °C with gentle shaking. After purification of the resulting immunoconjugates by ultrafiltration (Amicon ® Ultra-4, 30 kDa) followed by rinsing with 0.05 M ammonium acetate (pH 7), the concentration of the final solution was adjusted to 1.0 mg/mL.
Production of freeze-dried kits
Using a modified protocol previously described by Ackova et al. [27] , the solutions of the immunoconjugates containing 1% mannitol as cryoprotectant and bulking agent (50 µL in each vial), were freeze-dried using a Labconco Free Zone Stoppering Tray Dryer (Kansas City, Missouri, USA). Type I quality glass vials with a fill volume of 1 mL were used. The vials were homogeneously distributed on chilled shelves at 4 °C. The freezing process was performed at − 40 °C, at a rate of temperature drop of 1 °C/min and lasted for 5 h. The primary drying was carried out for 28 h, at pressure of 0.133 mBar and temperature of − 10 °C, at a rate of 0.15 °C/min. Then, a secondary drying was started as the temperature reached 25 °C, at a rate of 0.2 °C/min for 14 h. After completing the process of freeze drying, the vials were closed and stored at 4 °C for subsequent use.
Cold labeling of immunoconjugates with LuCl 3 and YCl 3
After solubilization of the selected freeze-dried immunoconjugate with sterile 0.9% NaCl solution with the volume 1.0 µL of a LuCl 3 solution with concentration of 1.0709 µg/ µL [equivalent to a no-carrier-added (nca) 177 Lu activity of 4377.1 MBq, which corresponds to the maximum tolerated dose (MTD) in patients] was added. Similarly, an YCl 3 solution with concentration of 1.1555 mg/µL (equivalent to a nca 90 Y activity of 1049.69 MBq corresponding to MTD in patients] was added to another identical vial containing the dissolved freeze-dried immunoconjugate)]. The resulting solutions p-SCN-Bn-DTPA-Tr and 1B4M-DTPA-Tr, were incubated, at room temperature, for 30 min, whereas for p-SCN-Bn-DOTA-Tr incubation was carried out at 40 °C for 60 min.
IR and Raman spectroscopy
A Varian 660 FT-IR spectrometer was employed for collection of the attenuated total reflectance (ATR) spectra (resolution 4 cm −1 , 64 scans) of the samples in the 2000-400 cm −1 region using a MIRAcle ZnSe ATR module (PIKE technologies). Corrections of the ATR spectra for the wavenumberdependent variations in the depth of penetration were made using the in-built ATR correct Algorithm 2 in the Varian Resolutions Pro software. The room temperature Raman spectra (2000-100 cm −1 ) were recorded on a micro-Raman multichannel spectrometer (Horiba JobinYvon LabRam 300 Infinity). The Raman effect was obtained using a 632.-nm beam from a He:Ne laser, without the use of the attenuation filter. An Olympus MPlanN confocal microscope with × 50 objective for selected and the spectral resolution was set to 4 cm −1 . A confocal hole of about 2 μm was used and the position on the sample surface was manipulated by a motorized x-y stage. The Raman shift was calibrated by using the Raman peak of silica located at 520.7 cm −1 . The acquisition time and the accumulation number were set to 20 s and 20 scans, respectively.
Freeze-dried, non-labeled samples were directly positioned under the laser beam of the instrument. After coldlabeling with non-radioactive isotopes following the procedure outlined above, samples were dried at 26 °C and the spectra of the resulting power were collected.
Results and discussion
Due to the intrinsic antibody's structural complex the analysis of possible physicochemical damage of protein-based medicines is usually very difficult compared to small-molecule drugs. Long-term stability is a common problem with monoclonal antibodies (MAbs), as it poses serious challenges to the development of stable freeze-dried formulations that are of high practical advantage when employed in a clinical setting. One of the major hurdles arises from the observation that IgG antibodies are multi-domain proteins, composed of four polypeptide chains connected by disulfide bonds and non-covalent forces. Touching just a single domain has a significant impact on protein's behavior and stability. In fact, they can denature independently to determine the unfolding of the protein's envelope, which is always followed by an irreversible aggregation process [28, 29] .
Vibrational spectroscopy could be a powerful and easyaccessible technique to get an insight into any alteration of the protein native state that might occur when the biological macromolecule has undergone severe processes such as chemical modification, freeze-drying or metal binding. In this study, the MAb trastuzumab (Tr) was selected as a representative example for assessing the efficiency of vibrational spectroscopy, under the form of infrared (IR) and Raman (RS) techniques, in detecting changes in the antibody's structure after its conjugation to selected bifunctional chelators (BFC), subsequent binding of the resulting immunoconjugate to Lu 3+ and Y 3+ and after a number of lyophilization processes of the various substances. Three Tables 1  and 2. IgG1 MAbs with molecular weight of approximately 150 kDa, including trastuzumab, are mostly composed of β-sheets, several β-turns and a small part of α-helix, the rest being disordered structure [30] . The spectra and characteristic band frequencies of proteins depend on hydrogen bond formation within the polypeptide chain, which differs between α-helixes and β-sheets.
RS recognizes the predominant β-sheet structure in IgG1 antibodies by identifying a characteristic band associated with the so-called Amide I region and a second more intense characteristic band associated with the so-called Amide III region. Amide I band originates from the envelope of stretching vibrations of the carbonyl groups (C=O). It is important to note that, if the polypeptide backbone is composed predominantly by α-helixes, the Amide I band is expected to occur at ~ 1655 cm −1 , whereas in MAbs and other macromolecules composed primarily by β-sheets, the characteristic Amide I band is found at ~ 1670 cm −1 . The Amide III band spring from coupled C-N stretching and N-H bending vibrations of the peptide residues. It is also important for the determination of the protein secondary β-sheet structure and is usually observed in the range between 1230 and 1300 cm ) is the most sensitive spectral region and mainly originates from the C=O stretching vibration of the amide group (~ 80%) with minor contributions from the out-of-plane CN stretching vibration and NH in-plane-bending. Amide II band (1480-1575 cm −1 ) is due to CN stretching vibrations (18-40%) in combination with NH bending (40-60%). The Amide I band is more protein conformational sensitive than Amide II band and is easily affected by side chain vibrations [17] [18] [19] . The Amide III band in proteins is more complex and the band wavenumbers depend on the backbone conformation (α-helix, 1328-1289 cm −1 , β-sheet, 1255-1244 cm −1 ). This band derives from the envelope of NH bending and CN stretching vibrations with a small contribution from C=O in-plane bending [17, 18, 34] . Other bands are less significant for the characterization of protein's secondary structure since these depend on the variable nature of side chains and hydrogen bonding. The Amide A and B are located at about 3300 cm −1 and 3100 cm −1 and originate from NH stretching. The bands Amide IV and V (625-800 cm −1 ), VI (537-606 cm −1 ) and VII (~ 200 cm −1 ) include out-of-plane motions of relevant functional groups (OCN, NH and C=O bending) and are also mixtures of coordinative displacements [17, 35] . However, due to our particular interest in screening the antibody's secondary structure, major scrutiny was focused on the most significant Amide I and III bands.
Analysis of RS spectra of pure antibody, unlabeled and metal-labeled BFC immunoconjugates after lyophilization, allowed obtaining an insight into the retention of the native protein structure by determining the presence of the characteristic amide bands. In all investigated protein samples, Amide I band was detected in the region characteristic of the predominant presence of the β-sheet structural motif (1668-1688 cm −1 ) corroborated by the observation that Raman spectra exhibit a medium intensity Amide III band in the 1235-1260 cm −1 region. The bands in the range 1453-1467 cm −1 were assigned to CH 2 deformation (ρCH 2 ) and those around 940-950 cm −1 to CH 3 deformations (ρCH 3 ). The bands occurring in the 1100-1170 cm −1 region, are connected to ν(C-C) vibrations of the skeletal backbone of the antibody.
Aminoacidic side chains are critical in stabilizing the antibody structures and, therefore, several Raman bands arising from vibrational modes of aminoacidic groups contribute significantly to the emergence of the observed spectral behavior. Aromatic amino acids phenylalanine (Phe), tyrosine (Tyr) and tryptophan (Trp) are mostly involved in hydrophobic and hydrogen bonding interactions and, thus, play an important role in the stabilization of the protein's structure. Bands associated with these species are strong and easily recognized and, hence, could be used as reliable markers of conformational changes, although some caution should be always used because they can overlap with amide bands related to other side-chain groups. In this study, tyrosine showed its vibrational modes around 647 cm −1 and in the interval 760-790 cm −1 . Tryptophan bands were detected around 757 cm −1 , 878 cm −1 and 1337 cm − . Signals associated with indole residues were found around 1560 cm −1 . The frequency vibrations in the range 1004-1060 cm −1 and 1610 cm −1 have been assigned to the presence of phenylalanine aminoacidic residues [31, 36, 37] . Raman spectra of pure trastuzumab revealed the presence of well-defined bands related to the presence of aromatic amino acids. It should be noted that, in some spectra of the immunoconjugates investigated here, we detected loss or changes in band intensity for characteristic bands associated to the presence of aromatic amino acids. Such tiny spectral variations can be explained by assuming that they result from the process of antibody conjugation to BFC, which might cause some overlapping of aromatic bands with those generated by the linkage of the various chelators to the protein moiety. Cysteine residues in IgG1 MAbs are usually involved in the formation of either intra-or inter-chain disulfide bridges (CS-SC). However, the presence of a negligible density of free sulfhydryl (SH) groups embedded in the antibody structure, was convincingly supported by the detection of Raman bands of very low intensity at 2500-2700 cm −1 . The occurrence of well-defined peaks associated to free sulfhydryl groups is always a signature of antibody's denaturation with generation of free heavy or light chains. In contrast, the detection of weak, but distinct Raman bands due to vibrations of disulfide bonds in the 400-700 cm −1 low-frequency region [31, 38] , were interpreted as strong markers of retention of intact disulfide bridges during the processes of BFC conjugation, metal binding and freeze-drying, without significant evidence of antibody denaturation. This conclusion is also supported by the presence of Amide I and III bands. The tentative assignments, given in Table 1 , agree with, and neatly complement, previously published data [21, 29, 31, 36] .
Protein aggregation is one of the major hurdles that may affect antibody's stability and, consequently, compromise its immunogenicity, biological activity and longevity. This process occurs when hydrophobic areas exposed onto the surface of neighborhood proteins become irreversibly attached to each other, thus forming large insoluble particles. Inappropriate handling during the conjugation process and inadequate protocols for carrying out lyophilization are usually the most relevant reasons boosting protein degradations and aggregation. In this work, Raman and IR spectroscopy have been used for testing the presence of aggregates in our samples. Raman spectra exhibiting a well-defined peak at ~ 1634 cm −1 are commonly interpreted as an indication of increased intramolecular H-bonding in the β-sheet structure, which is, in turn, a signature of the occurrence of some degree of aggregation [39] . The absence of this characteristic band in Raman spectra of our samples was considered as a compelling experimental evidence of retention of the antibody native state combined with the absence of any protein aggregation.
Raman bands for mannitol formulations were less intense and showed peaks at 1554 cm . 1 . This shift is associated with ring vibrations due to the amino acids and overlapped with some bands from the chelators [36] . Analysis of IR spectra were also of high value in detecting alterations of antibody's integrity. Actually, the Amide I IR band is the most significant marker for investigating variations in the protein's secondary structure, although Amide II and Amide III bands can also play a considerable role to identify any changes in the native state. Due to the high sensitivity of the Amide I band to the actual arrangement of the protein backbone, the absorption interval varies between α-helix and β-sheet conformations. α-helical structures show absorption around 1655 cm −1 , while the position of this band in β-sheet secondary structures occurs in the range 1640-1612 cm −1 [18, 22, 40] . In our spectra, a strong Amide I band was detected in the region of 1633-1645 cm −1 , thus suggesting the predominant presence of a β-sheet conformation and conservation of the secondary structure of the antibody. Amide II band, although sensitive to protein's secondary structure, should not be taken as a reliable marker of structural deformations [40] . In accordance with previously published data [18] , characteristic peaks were found in the range 1480-1575 cm −1 in our spectra. Observation of a well-defined Amide III band could be useful for analysis of antibody structure, and for determination of the occurrence of α-helixes and β-sheets. Yet, in many situations, these bands have shown a weak intensity due to the overlap with other vibrations [36] . In our samples, the observation of Amide III bands supported the existence of high-percentage β-sheet conformation in trastuzumab. The other amide bands (IV-VII) were insignificant and have been neglected for secondary structure determination. However, it is notable that their appearances in our IR spectra was consistent with previously published data [18, 22] . The tentative assignment of IR bands is shown in Table 2 .
The high sensitivity of the Amide I band can be also exploited for identification of protein folding, unfolding and potential aggregation. Since an absorption band found near or below 1620 cm −1 [18, 36] is indicative of protein's aggregation, the absence of these peaks in IR spectra was consistent with previous conclusions, drawn from the analysis of Raman spectra, supporting the picture that the freezedrying process did not induce any detectable aggregation of the trastuzumab moiety and its native structure was fully preserved.
Conclusions
Vibrational techniques (IR and Raman spectroscopy) are useful tools for investigation of conformational changes in the antibody after derivatization with a bifunctional chelator and during the freeze-drying and non-radioactive metallic labeling. The minor difference in the IR and Raman spectra of immunoconjugates (intensity changes, absence of some low-intensity peaks) in comparison with native trastuzumab unveiled that only insignificant changes occurred in the protein's structure as a result of chelator binding and metalation. Conversely, the presence in the reported spectra of the characteristic amide bands bolstered the view that the freezedried formulations was able to fully retain anti-HER2 primitive activity of trastuzumab and, therefore, could be conveniently employed for efficient radiolabeling with the medical radioisotopes 177 Lu and 90 Y, which are attractive candidates for radionuclide therapy of HER2 positive breast cancer. The process of freeze-drying did not affect significantly the structure and stability of the conjugated antibody, thus suggesting that freeze-drying methods prosed here might constitute a 
